深城交(301091.SZ):股東股份延長鎖定到期日至2025年4月28日
格隆匯11月25日丨深城交(301091.SZ)公佈,公司股票於2021年10月29日上市,自2021年10月29日至2021年11月25日,公司股票連續20個交易日的收盤價均低於發行價36.50元/股,觸發前述股份鎖定期延長承諾的履行條件。
公司控股股東深圳市智慧城市科技發展集團有限公司原股份鎖定到期日為2024年10月28日,本次延長後鎖定到期日為2025年4月28日;通過深圳市深研交通投資股份有限公司間接持有公司股份的董事、高級管理人員張曉春、林濤、田鋒、黎木平、楊宇星、宋家驊、徐惠農原股份鎖定到期日為2024年10月28日,本次延長後鎖定到期日為2025年4月28日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.